Cormorant Global Healthcare Master Fund, LP, 10% Owner at EyePoint Pharmaceuticals, Inc. (EYPT), bought 3,810,024 shares at $19.88 ($83.1M) on 2023-12-04, disclosed to the SEC on 2023-12-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.80 | 321,259 | $6.0M | 7.3% |
| 2 | $18.80 | 321,259 | $6.0M | 7.3% |
| 3 | $19.88 | 945,664 | $18.8M | 22.6% |
| 4 | $19.88 | 945,664 | $18.8M | 22.6% |
| 5 | $20.62 | 122,625 | $2.5M | 3.0% |
| 6 | $20.62 | 122,625 |
| $2.5M |
| 3.0% |
| 7 | $21.87 | 79,805 | $1.7M | 2.1% |
| 8 | $21.87 | 79,805 | $1.7M | 2.1% |
| 9 | $22.80 | 28,090 | $640K | 0.8% |
| 10 | $24.01 | 37,081 | $890K | 1.1% |
| 11 | $24.01 | 37,081 | $890K | 1.1% |
| 12 | $24.87 | 39,899 | $992K | 1.2% |
| 13 | $24.87 | 39,899 | $992K | 1.2% |
| 14 | $25.88 | 65,086 | $1.7M | 2.0% |
| 15 | $25.88 | 65,086 | $1.7M | 2.0% |
| 16 | $26.73 | 53,109 | $1.4M | 1.7% |
| 17 | $26.73 | 53,109 | $1.4M | 1.7% |
| 18 | $27.87 | 27,425 | $764K | 0.9% |
| 19 | $27.87 | 27,425 | $764K | 0.9% |
| 20 | $28.78 | 8,168 | $235K | 0.3% |
| 21 | $28.78 | 8,168 | $235K | 0.3% |
| 22 | $29.91 | 18,601 | $556K | 0.7% |
| 23 | $29.91 | 18,601 | $556K | 0.7% |
| 24 | $30.74 | 15,582 | $479K | 0.6% |
| 25 | $30.74 | 15,582 | $479K | 0.6% |
| 26 | $31.83 | 86,713 | $2.8M | 3.3% |
| 27 | $31.83 | 86,713 | $2.8M | 3.3% |
| 28 | $33.08 | 41,824 | $1.4M | 1.7% |
| 29 | $33.08 | 41,824 | $1.4M | 1.7% |
| 30 | $33.75 | 19,866 | $670K | 0.8% |
| 31 | $33.75 | 19,866 | $670K | 0.8% |
| 32 | $34.49 | 8,260 | $285K | 0.3% |
| 33 | $34.49 | 8,260 | $285K | 0.3% |
| Total | $21.81 avg | 3,810,024 | $83.1M | 100% |
| Filing → |
| DRUG | BUY | 2024-10-17 | $6.4M | — | Filing → |
| CRBP | BUY | 2024-09-24 | $14.0M | — | Filing → |
| EYPT | BUY | 2024-04-22 | $21.0M | — | Filing → |